75W-25496-46159
2 vaccinations
5 coded responses
23 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 015 / MA
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Registered in v-safe
-
2021-03-23
Dose 1 — Pfizer-BioNTech
- 2021-03-23
-
2021-03-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Redness · Fatigue or tirednessAdult check-in
-
2021-03-25
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-26
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-27
-
2021-03-28
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-30
- 2021-04-06
- 2021-04-13
-
2021-04-14
Dose 2 — Pfizer-BioNTech
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-04-17
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: Swollen gland in armpit on same side as injection site. Started yesterdayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-19
- 2021-04-21
- 2021-04-28
-
2021-05-05
Survey response — day 21, dose 2MedDRA: Fatigue — Feeling: FairFree text: Extreme fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-12
- 2021-05-19
- 2021-05-26
-
2021-07-14
Survey response — 3 months, dose 2MedDRA: Cough, Nasal congestion, Nasopharyngitis, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cough, cold, nasal congestion, low grade feverMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-10-13
Survey response — 6 months, dose 2MedDRA: Heavy menstrual bleeding, Housebound, Menopausal symptoms — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: 2 extremely heavy perimenopausal periods, to the point of needing adult diapers and unable to leave the house.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-16
Survey response — 12 months, dose 2MedDRA: Blood pressure abnormal, COVID-19, Heavy menstrual bleeding — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: I had covid twice, excessively long and heavy periods, blood pressure crisisMedDRA releases: 2024-11 · check-in free text available
-
2022-04-16
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2022-04-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-23 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-16 | Unsuccessful |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen gland in armpit on same side as injection site. Started yesterday
Release 8 — day 21, dose 2
Symptoms: Extreme fatigue
Release 9 — 3 months, dose 2
Symptoms: Cough, cold, nasal congestion, low grade fever
Release 10 — 6 months, dose 2
Symptoms: 2 extremely heavy perimenopausal periods, to the point of needing adult diapers and unable to leave the house.
Release 11 — 12 months, dose 2
Symptoms: I had covid twice, excessively long and heavy periods, blood pressure crisis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blood pressure abnormal | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Housebound | · | · | ✓ |
| SD | Menopausal symptoms | · | · | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release